Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis
- 27 April 2015
- journal article
- review article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 35 (6), 683-690
- https://doi.org/10.1038/onc.2015.128
Abstract
CEP55 was initially identified as a pivotal component of abscission, the final stage of cytokinesis, serving to regulate the physical separation of two daughter cells. Over the past 10 years, several studies have illuminated additional roles for CEP55 including regulating the PI3K/AKT pathway and midbody fate. Concurrently, CEP55 has been studied in the context of cancers including those of the breast, lung, colon and liver. CEP55 overexpression has been found to significantly correlate with tumor stage, aggressiveness, metastasis and poor prognosis across multiple tumor types and therefore has been included as part of several prognostic 'gene signatures' for cancer. Here by discussing in depth the functions of CEP55 across different effector pathways, and also its roles as a biomarker and driver of tumorigenesis, we assemble an exhaustive review, thus commemorating a decade of research on CEP55.This publication has 85 references indexed in Scilit:
- Age-Specific Gene Expression Signatures for Breast Tumors and Cross-Species Conserved Potential Cancer Progression Markers in Young WomenPLOS ONE, 2013
- Cytotoxic T Lymphocytes Efficiently Recognize Human Colon Cancer Stem-Like CellsThe American Journal of Pathology, 2011
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective studyThe Lancet Oncology, 2011
- The biology of cancer testis antigens: Putative function, regulation and therapeutic potentialMolecular Oncology, 2011
- Fibulin-5, an integrin-binding matricellular protein: its function in development and diseaseJournal of Cell Communication and Signaling, 2009
- Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissueBreast Cancer Research and Treatment, 2009
- Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progressionNature, 2008
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancersNature Genetics, 2006
- The p53 tumour suppressor geneNature, 1991